Moreover, gene-drug interaction network was constructed by CTD to find that multiple ESM1 inhibitors, including cisplatin, colchicine, quercetin, vinblastine, and vincristine, might serve as potential targets for the therapy of ACC patients with ESM1 high expression. The gene discussed is ESM1; the disease is adrenal cortex carcinoma.